Reconstitution raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual descriptor; not a measure of purity |
| Solubility class | Freely soluble in water | Aqueous dissolution may require gentle mixing |
| Typical storage (powder) | −20 °C or below, desiccated | Protect from light and ambient moisture |
| Typical storage (solution) | 2–8 °C, short term | Freeze aliquots where longer holding is needed |
| Purity assessment | Reversed-phase HPLC, area percent | Values depend on column, gradient, and detection wavelength |
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
== Signs and symptoms == The first skin changes in calciphylaxis lesions are mottling of the skin and induration in a livedo reticularis pattern. As tissue thrombosis and infarction occurs, a black, leathery eschar in an ulcer with adherent black slough develops. Surrounding the ulcers is usually a plate-like area of indurated skin. These lesions are always extremely painful and most often occur on the lower extremities, abdomen, buttocks, and penis. Lesions are also commonly multiple and bilateral. Because the tissue has infarcted, wound healing seldom occurs, and ulcers are more likely to become secondarily infected. Many cases of calciphylaxis lead to systemic bacterial infection and death. Calciphylaxis is characterized by the following histologic findings:
The application of carbetocin does not affect a non-pregnant uterus with lower oxytocin receptor expression. Carbetocin also functions to thicken the blood, further preventing post-partum hemorrhage. Carbetocin should not be used to induce or augment labor since it could cause cardiac or respiratory distress to mother or infant.
== Fireproofing of structural steel == In a building fire, structural steel loses strength as the temperature increases. In order to maintain the structural integrity of the steel frame, several fireproofing measurements are taken:
== External links == Electron+Transport+Chain+Complex+Proteins at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Khan Academy, video lecture KEGG pathway: Oxidative phosphorylation, overlaid with genes found in Pseudomonas fluorescens Pf0-1. Click "help" for a how-to.
Sources: en.wikipedia.org
=== Official demolition === On 13 June 1990, the East German Border Troops officially began dismantling the Wall, beginning in Bernauer Straße and around the Mitte district. From there, demolition continued through Prenzlauer Berg/Gesundbrunnen, Heiligensee and throughout the city of Berlin until December 1990. According to estimates by the border troops, a total of around 1.7 million tonnes of building rubble was produced by the demolition. Unofficially, the demolition of the Bornholmer Straße crossing began because of construction work on the railway. This involved a total of 300 GDR border guards and—after 3 October 1990—600 Pioneers of the Bundeswehr. These were equipped with 175 trucks, 65 cranes, 55 excavators and 13 bulldozers. Virtually every road that was severed by the Berlin Wall, every road that once linked from West Berlin to East Berlin, was reconstructed and reopened by 1 August 1990. In Berlin alone, 184 km (114 mi) of wall, 154 km (96 mi) border fence, 144 km (89 mi) signal systems and 87 km (54 mi) barrier ditches were removed. What remained were six sections that were to be preserved as a memorial. Various military units dismantled the Berlin/Brandenburg border wall, completing the job in November 1991. Painted wall segments with artistically valuable motifs were put up for auction in 1990 in Berlin and Monte Carlo. On 1 July 1990, the day East Germany adopted the West German currency, all de jure border controls ceased, although the inter-German border had become meaningless for some time before that. The demolition of the Wall was completed in 1994.
July 24 2026 Iran war: Trump warns that the US will use Iranian money in its possession or control to pay for "any and all damages" to ships and cargo. The US conducts its 13th consecutive evening of strikes in Iran. The FDA approves a non-prescription, fixed-dose pill combining Tylenol and naproxen for pain relief in alignment with Trump's healthcare plan to make safe pharmaceutical drugs available over-the-counter. July 25 – 2026 Iran war: US forces cease overnight strikes against Iran after 13 nights of attacks. President Trump reportedly pauses plans for further escalation, citing depleted Pentagon stocks of regional air defence munitions, particularly Patriot antimissile interceptors, and a recommendation from CENTCOM commander Admiral Brad Cooper to halt the Hormuz campaign unless the United States was prepared to escalate. July 27 Three people are killed and four others are injured, including a 2-year-old boy in a shooting at a food festival in Seattle. The Office of the Attending Physician says that Senator Mitch McConnell remains in a rehabilitation facility and has not been medically cleared to return to the Senate, more than six weeks after being hospitalized following a fall. McConnell is undergoing multiple daily physical therapy sessions but gives no timetable for his return and says he will miss Kentucky's annual Fancy Farm Picnic. July 30 The US awards Lockheed Martin a record $58.6 billion contract to manufacture Patriot missile interceptors, as the Middle Eastern crisis and the Russo-Ukrainian war reduced global US military armament stocks.
Many pathways and signals lead to apoptosis, but these converge on a single mechanism that actually causes the death of the cell. After a cell receives stimulus, it undergoes organized degradation of cellular organelles by activated proteolytic caspases. In addition to the destruction of cellular organelles, mRNA is rapidly and globally degraded by a mechanism that is not yet fully characterized. mRNA decay is triggered very early in apoptosis. A cell undergoing apoptosis shows a series of characteristic morphological changes. Early alterations include:
Sources: en.wikipedia.org
Edelman, Under Secretary of Defense for Policy, described the shelling of the Georgian villages in hearing of the United States Senate Committee on Armed Services and said that Russian peacekeepers neglected their obligation to curb artillery fire and that Georgian military began to quell artillery sites in South Ossetia on the night of 7 August. Edelman said that although Russian officials had claimed that Russia's goal was defense of Russian citizens and peacekeepers, "What became clear is there never seemed to be a limit to Russia's operational – nor strategic – aims." Edelman said that the Russian invasion was pre-planned. According to Edelman, although Putin had blamed the United States for arming Georgia, the United States had never intended for the Georgian forces to oppose Russia. Edelman further stated, "Russia was clearly adding to tension in order to provoke a Georgian response." Edelman said that the first modern Russian invasion of foreign country "sends a chilling message" about new Russian foreign policy. In September 2008, Dana Rohrabacher (a senior Republican member of the United States House of Representatives) argued at a United States House Committee on Foreign Affairs meeting that Georgia started the fighting on August 7, citing alleged unnamed intelligence reports. Telegraph noted the Russian media paid much attention to Rohrabacher's remarks. In September 2008, Senator Hillary Clinton proposed to create a U.S. commission to study the war.
In a broad way, it usually includes a test of ruggedness among inter-collaborators, or a test of robustness within an organization However, the U.S. Food and Drug Administration (FDA) has specifically defined it for its administration, as "System suitability testing is an integral part of many analytical procedures. The tests are based on the concept that the equipment, electronics, analytical operations and samples to be analyzed constitute an integral system that can be evaluated as such. System suitability test parameters to be established for a particular procedure depend on the type of procedure being validated". In some cases of analytical chemistry, a system suitability test could be rather a method specific than universal. Such examples are chromatographic analysis, which is usually media (column, paper or mobile solvent) sensitive However to the date of this writing, this kind of approaches are limited to some of pharmaceutical compendial methods, by which the detecting of impurities, or the quality of the intest analyzed are critical (i.e., life and death). This is probably largely due to:
== Personal life == Fischer married Agnes Gerlach in 1888. She died seven years later, leaving him a widower with three sons. The younger two died during their military service in World War I, but the oldest, Hermann, became an organic chemist. Fischer died in Berlin on 15 July 1919 at the age of 66. He was Protestant
Sources: en.wikipedia.org
Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.
There is no single agreed limit, and laboratory practice varies widely. Refrigeration slows degradation, and freezing aliquots is often described for longer holding. Any visible cloudiness or precipitate indicates the solution should be discarded.
Mass spectrometry provides the most direct confirmation through molecular mass. Reversed-phase chromatography supports purity assessment, and peptide mapping or amino acid analysis can corroborate sequence. No single method establishes both purity and identity on its own.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.